UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K/A

(Amendment No. 2)

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 5, 2019

 

Health Insurance Innovations, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-35811   46-1282634
(State or other jurisdiction
of incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

15438 N. Florida Avenue, Suite 201

Tampa, Florida

  33613
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (813) 397-1187

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Class A Common Stock, $0.001 par value   HIIQ   Nasdaq Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

 
 

 

EXPLANATORY NOTE

 

Health Insurance Innovations, Inc. (the “Company”) is filing this Amendment No. 2 on Form 8-K/A solely to file a consent from the independent registered public accounting firm of Grant Thornton LLP to the incorporation by reference of its report dated August 21, 2019 with respect to the combined financial statements of TogetherHealth Insurance, LLC and affiliated companies into registration statements of the Company. Such consent was omitted in the Amendment No. 1 on Form 8-K/A filed by the Company on August 21, 2019.

 

Item 9.01. Financial Statements and Exhibits

 

(a) Exhibits.

 

  Exhibit No.   Description
       
  23.1   Consent of Independent Certified Public Accountants of TogetherHealth Insurance, LLC and affiliated companies, Grant Thornton LLP.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  HEALTH INSURANCE INNOVATIONS, INC.
     
  By: /s/ Michael D. Hershberger
  Name: Michael D. Hershberger
  Title: Chief Financial Officer

 

Date: August 22, 2019

 

 
 

 

 

CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

 

We have issued our report dated August 21, 2019, with respect to the combined financial statements of TogetherHealth Insurance, LLC and affiliated companies for the year ended December 31, 2018 included in the Current Report of Health Insurance Innovations, Inc. on Form 8-K/A dated August 21, 2019. We consent to the incorporation by reference of said report in the Registration Statements of Health Insurance Innovations, Inc. on Forms S-3 (File No. 333-217744, File No. 333-201989, and File No. 333-193842) and on Forms S-8 (File No. 333-219711, File No. 333-212997, File No. 333-207907, and File No. 333-186503). 

 

/s/ GRANT THORNTON LLP  

 

Tampa, Florida

August 21, 2019